3-(5-chloro-1-methylindol-3-yl)propanoic acid | 943825-65-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 3-(5-chloro-1-methylindol-3-yl)propanoic acid
• 英文别名: 3-(5-chloro-1-methyl-1H-indol-3-yl)propanoic acid
• CAS: 943825-65-8
• 化学式: C₁₂H₁₂ClNO₂
• 分子量: 237.686
• InChiKey: MOYARHQOLTYZIL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  42.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(5-chloro-1-methylindol-3-yl)propanoic acid 、 1,2-dimethyl-5-trifluoromethoxy-1H-indole-3-methanamine 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 3.17h， 以79%的产率得到3-(5-chloro-1-methyl-1H-indol-3-yl)-N-((1,2-dimethyl-5-(trifluoromethoxy)-1H-indol-3-yl)methyl)propanamide
  参考文献：
  名称：

  Synthesis, characterization, and SAR studies of new (1H-indol-3-yl)alkyl-3-(1H-indol-3-yl)propanamide derivatives as possible antimicrobial and antitubercular agents

  摘要：

  In this article, we report herein the SAR studies of a series of (1H-indol-3-yl)alkyl-3-(1H-indol-3-yl)propanamide 10(a-j), 11(a-j). The synthesized compounds were evaluated for their preliminary in vitro antibacterial, antifungal activity and were screened for antitubercular activity against Mycobacterium tuberculosis H37Rv strain. The synthesized compounds displayed interesting antimicrobial activity.

  DOI：

  10.1007/s00044-012-0451-x
• 作为产物：
  描述：

  5-chloro-1-methyl-1H-indole-3-carbaldehyde 在 镍 sodium hydroxide 、 氢气 、 sodium hydride 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 反应 2.0h， 生成 3-(5-chloro-1-methylindol-3-yl)propanoic acid
  参考文献：
  名称：

  Synthetic N-pyridinyl(methyl)-indol-3-ylpropanamides as new potential immunosuppressive agents

  摘要：

  Several N-pyridinyl(methyl)-indol-3-ylpropanamides were synthesized and pharmacological evaluations of their immumosuppressive potential were performed. Among thirteen compounds tested in vitro on murine T proliferation, three showed interesting inhibiting activity. For the most active compound (propanamide 18), immunosuppressive activity was documented both in vitro on human T lymphocytes proliferation and in vivo on mice delayed-type hypersensitivity. These experimental data demonstrated that these compounds hold potential as immunosuppressive agents. (c) 2007 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2006.12.013

文献信息

• [EN] HIGHLY ACTIVE SELF-SUFFICIENT NITRATION BIOCATALYSTS<br/>[FR] BIOCATALYSEURS DE NITRATION AUTO-SUFFISANTS HAUTEMENT ACTIFS
  申请人：UNIV FLORIDA

  公开号：WO2018081456A1

  公开（公告）日：2018-05-03

  The disclosure relates to the field of fusion proteins. In some aspects, the disclosure relates to artificial fusion proteins comprising cytochrome P450 enzymes linked to reductase enzymes and uses thereof. In some aspects, the disclosure relates to compounds produced by artificial cytochrome P450 enzymes.

  该披露涉及融合蛋白的领域。在某些方面，该披露涉及人工融合蛋白，其中包括与还原酶酶相连的细胞色素P450酶，并其用途。在某些方面，该披露涉及由人工细胞色素P450酶产生的化合物。
• WHOLE CELL PROCESSES TO PRODUCE NITROAROMATICS
  申请人：University of Florida Research Foundation, Incorporated

  公开号：US20210108237A1

  公开（公告）日：2021-04-15

  The disclosure relates, in some aspects, to compositions and methods useful for production of nitrated aromatic molecules. The disclosure is based, in part, on whole cell systems expressing artificial fusion proteins comprising cytochrome P450 enzymes linked to reductase enzymes. In some aspects, the disclosure relates to methods of producing nitrated aromatic molecules in whole cell systems having artificial fusion proteins comprising cytochrome P450 enzymes linked to reductase enzymes.
• [EN] ARTIFICIAL SELF-SUFFICIENT CYTOCHROME P450S<br/>[FR] CYTOCHROMES P450 AUTOSUFFISANTS ARTIFICIELS
  申请人：UNIV FLORIDA

  公开号：WO2016134145A9

  公开（公告）日：2017-02-16

  [EN] The disclosure relates to the field of fusion proteins. In some aspects, the invention relates to artificial fusion proteins comprising cytochrome P450 enzymes linked to reductase enzymes and uses thereof. In some aspects, the disclosure relates to compounds produced by artificial cytochrome P450 enzymes.
  [FR] La présente invention se rapporte au domaine des protéines hybrides. Dans certains aspects, l'invention concerne des protéines hybrides artificielles comprenant des enzymes du cytochrome P450 liées à des enzymes réductase et leurs utilisations. Dans certains aspects, l'invention concerne des composés produits par des enzymes du cytochrome P450 artificielles.